Back to Search
JIANA MENENDEZ, MD
MD
Family Medicine Physician
NPI: 1720433394IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
299729(NY)MD27550(ME)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Class of 2016
Research & Publications (20)
Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer.
PMID 19181734·Clin Chem·2009
6-review
Extra-virgin olive oil polyphenols inhibit HER2 (erbB-2)-induced malignant transformation in human breast epithelial cells: relationship between the chemical structures of extra-virgin olive oil secoiridoids and lignans and their inhibitory activities on the tyrosine kinase activity of HER2.
PMID 19082476·Int J Oncol·2009
8-other
Analyzing effects of extra-virgin olive oil polyphenols on breast cancer-associated fatty acid synthase protein expression using reverse-phase protein microarrays.
PMID 18813848·Int J Mol Med·2008
8-other
tabAnti-HER2 (erbB-2) oncogene effects of phenolic compounds directly isolated from commercial Extra-Virgin Olive Oil (EVOO).
PMID 19094209·BMC Cancer·2008
8-other
Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin) in HER2-overexpressing breast cancer cells.
PMID 17490486·BMC Cancer·2007
4-observational
Transphosphorylation of kinase-dead HER3 and breast cancer progression: a new standpoint or an old concept revisited?
PMID 17983482·Breast Cancer Res·2007
8-other
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis.
PMID 17882277·Nat Rev Cancer·2007
6-review
A genomic explanation connecting "Mediterranean diet", olive oil and cancer: oleic acid, the main monounsaturated fatty acid of olive oil, induces formation of inhibitory "PEA3 transcription factor-PEA3 DNA binding site" complexes at the Her-2/neu (erbB-2) oncogene promoter in breast, ovarian and stomach cancer cells.
PMID 16406575·Eur J Cancer·2006
8-other
Trastuzumab in combination with heregulin-activated Her-2 (erbB-2) triggers a receptor-enhanced chemosensitivity effect in the absence of Her-2 overexpression.
PMID 16847284·J Clin Oncol·2006
8-other
Oncogenic properties of the endogenous fatty acid metabolism: molecular pathology of fatty acid synthase in cancer cells.
PMID 16778562·Curr Opin Clin Nutr Metab Care·2006
6-review
Mediterranean dietary traditions for the molecular treatment of human cancer: anti-oncogenic actions of the main olive oil's monounsaturated fatty acid oleic acid (18:1n-9).
PMID 17168666·Curr Pharm Biotechnol·2006
6-review
DNA topoisomerase IIalpha (TOP2A) inhibitors up-regulate fatty acid synthase gene expression in SK-Br3 breast cancer cells: in vitro evidence for a 'functional amplicon' involving FAS, Her-2/neu and TOP2A genes.
PMID 17089011·Int J Mol Med·2006
8-other
Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis.
PMID 15607568·Med Hypotheses·2005
8-other
RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
PMID 15583825·Int J Mol Med·2005
8-other
A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway.
PMID 15592521·Oncogene·2005
8-other
In support of fatty acid synthase (FAS) as a metabolic oncogene: extracellular acidosis acts in an epigenetic fashion activating FAS gene expression in cancer cells.
PMID 15523670·J Cell Biochem·2005
8-other
Effect of gamma-linolenic acid on the transcriptional activity of the Her-2/neu (erbB-2) oncogene.
PMID 16264182·J Natl Cancer Inst·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5 BUCKNAM RD STE 2C
FALMOUTH, ME 04105 - Phone
- (207) 781-1500
Quick Facts
- NPI
- 1720433394
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 10
- Publications
- 20
Are you this provider?
Claim Your Profile